Director TitleAgeSince
Director/Board Member - 30/09/2010
Director/Board Member - 30/09/2010
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
-0.21%+1.36%+23.01%+73.63% 48.77B
-1.61%-0.29%+51.58%+118.38% 40.67B
-0.80%+0.63%+16.18%+86.51% 12.27B
-0.63%+0.81%-9.88%+14.15% 12.11B
+0.57%+1.73%+31.59%+153.11% 9.28B
-1.30%-2.71%+24.54%+44.90% 7.55B
-1.11%+0.24%+27.38%+220.96% 7.35B
-0.62%-0.84%+44.70%-11.26% 7.3B
-0.13%-0.16%-40.47%+15.85% 5.25B
Average +17,989.41%+1.04%+18.74%+79.58% 16.73B
Weighted average by Cap. -0.53%+1.25%+27.18%+86.50%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock